Trial ID:
IRB-25-8600
Wesleigh Fowler Edwards, MD PhD

Inclusion Criteria

Patients must:

  • Be 18 years or older
  • Have a HER2-expressing solid tumor
  • Have received at least 2 lines of standard therapy

Exclusion Criteria

Patients must not:

  • Have a history of severe heart disease
  • Have active autoimmune diseases
  • Have prior malignancies
  • Have known or suspected human immunodeficiency virus infection
  • Be pregnant or breastfeeding

Additional Info

All treatments and physician visits during the study will take place at Prebys Cancer Center at Mercy Hillcrest.

For more information search NCT#: 06293898 at www.clinicaltrials.gov

Contact Info:

  • Clinical Research Services
  • crsleadership@scrippshealth.org